Today's Award Lecture: Brian T. Chait
Today at 4:45 p.m., Brian T. Chait of the Rockefeller University in New York will receive the 2015 ASMS Award for a Distinguished Contribution in Mass Spectrometry, and will present a lecture about his research.
Chait receives this award for his recognition and demonstration of the link between protein structure and conformation and electrospray ionization mass spectra. His discovery that a protein’s solution-phase conformation affects its electrospray ionization mass spectrometry (ESI-MS) charge state distribution made it possible for MS to probe higher order macromolecular structures. It also fostered a flood of applications of MS to noncovalent assemblies, hydrogen–deuterium exchange, probes of gas-phase protein structure, and ultimately native mass spectrometry.
In 1991, the Chait laboratory first demonstrated that electrosprayed cytochrome c molecules assumed about twice as much charge when sprayed from pH 2.6 than from pH 5.2 water (1), by probing conformational changes in proteins using hydrogen–deuterium exchange (2) and by monitoring solution-phase thermal denaturation processes by ESI-MS.
At the time of Chait’s achievement, few scientists were capable of spraying 100% aqueous solutions. However, Chowdhury and Chait demonstrated that electropolished needles could electrospray water at voltages sufficiently below those inducing dielectric breakdown (3). That ability to electrospray 100% water was key to observing the charge state distribution differences associated with natively folded proteins. Equally important was Chait’s ability to rationalize and prove that the source of the observed charge state distribution difference had to be solution-phase structure.
The lecture will be held in Hall 5 on level 1.
References
(1) S.K. Chowdury, V. Katta, and B.T. Chait, J. Am. Chem. Soc.112(24), 9012 (1990).
(2) V. Katta, B.T. Chait, Rapid Commun. Mass Spectrom. 5(4), 214 (1991).
(3) S.K. Chowdury and B.T. Chait, Anal. Chem. 63(15), 1660 (1991).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
